Long-term disease management in practice — a nephrology viewpoint

Abstract

In multidisciplinary settings, real-world registries complement randomized trial evidence, although confirmatory data are still limited. When protocols are compared, training and accreditation are decisive for reproducibility, pending validation in prospective studies.

Across multiple cohorts, threshold harmonization is still an open question, which has direct implications for daily practice. Across multiple cohorts, early intervention correlates with better long-term outcomes, which has direct implications for daily practice. In routine practice, integrating quantitative measures reduces subjective bias, with meaningful differences between subgroups. From a workflow perspective, variability between operators remains a key limitation, a finding echoed by several independent groups.

Expert commentary

According to consensus recommendations, training and accreditation are decisive for reproducibility, with meaningful differences between subgroups. Longitudinal data show that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, a finding echoed by several independent groups. When protocols are compared, early intervention correlates with better long-term outcomes, and this trend is expected to continue. Longitudinal data show that standardized reporting improves comparability between centers, as discussed in the accompanying commentary.

When protocols are compared, threshold harmonization is still an open question, a finding echoed by several independent groups. From a workflow perspective, early intervention correlates with better long-term outcomes, which has direct implications for daily practice.

Practical implications

Emerging evidence indicates that pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary. From a workflow perspective, early intervention correlates with better long-term outcomes, although confirmatory data are still limited.

Longitudinal data show that patient selection criteria deserve closer scrutiny, a finding echoed by several independent groups. Longitudinal data show that cost considerations continue to shape adoption in smaller units, a finding echoed by several independent groups. In routine practice, cost considerations continue to shape adoption in smaller units, with meaningful differences between subgroups. In multidisciplinary settings, early intervention correlates with better long-term outcomes, which has direct implications for daily practice. When protocols are compared, cost considerations continue to shape adoption in smaller units, particularly in resource-constrained settings.